An Investment Agreement was signed between Fluorinex and Syneron Medical, following which Syneron will chair the Board of Directors and become a strategic partner of Fluorinex.
Syneron Medical Ltd. (NASDAQ: ELOS) develops, manufactures, sells and supports systems and technology for non-invasive aesthetic medical applications. Its medical aesthetic devices are powered by the proprietary, patented elos combined-energy technology of Bi-Polar Radio Frequency and Light. Syneron's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite.